Analytic for Hemodynamic Instability – Predictive Indicator (AHI-PI), from Weil Institute spin-off Fifth Eye, outperforms traditional vital sign measurements in early detection, offering a 26-hour lead time and expanding applications beyond the ICU.
Read MoreThe Analytic for Hemodynamic Instability (AHI) from Weil Institute partner Fifth Eye, Inc. provides clinically significant lead time in predicting onset of instability before vital signs.
Read MoreFifth Eye's AHI System is the only FDA-cleared medical device software of its kind, detecting hemodynamic instability that can signal patient decompensation ahead of vital signs.
Read More
